Browsing byAuthorSatija, S

Jump to a point in the index:
Showing results 1 to 20 of 53  next >
Issue DateTitleAuthor(s)
2021-07-28Targeting Cellular Signalling Pathways in Lung DiseasesDua, K; Löbenberg, R; Luzo, ACM; Shukla, S; Satija, S
2021-05Current-status and applications of polysaccharides in drug delivery systemsPrasher, P; Sharma, M; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Anand, K; Sharma, N; Dureja, H; Jha, NK; Gupta, G; Gulati, M; Singh, SK; Chellappan, DK; Paudel, KR; Hansbro, PM; Dua, K
2021-02-04Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation.Mehta, M; Paudel, KR; Shukla, SD; Shastri, MD; Satija, S; Singh, SK; Gulati, M; Dureja, H; Zacconi, FC; Hansbro, PM; Chellappan, DK; Dua, K
2020-12-01Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative studyPandey, NK; Singh, SK; Gulati, M; Kumar, B; Kapoor, B; Ghosh, D; Kumar, R; Khursheed, R; Awasthi, A; Kuppusamy, G; Wadhwa, S; Satija, S; Dureja, H; Jain, SK; Chellappan, DK; Anand, K; Mehta, M; Dua, K
2020-12-01Development of modified apple polysaccharide capped silver nanoparticles loaded with mesalamine for effective treatment of ulcerative colitisKaur, G; Singh, SK; Kumar, R; Kumar, B; Kumari, Y; Gulati, M; Pandey, NK; Gowthamarajan, K; Ghosh, D; Clarisse, A; Wadhwa, S; Mehta, M; Satija, S; Dua, K; Dureja, H; Gupta, S; Singh, PK; Kapoor, B; Chitranshi, N; Kumar, A; Porwal, O
2020-11-30Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113.Aljabali, AAA; Bakshi, HA; Hakkim, FL; Haggag, YA; Al-Batanyeh, KM; Zoubi, MSA; Al-Trad, B; Nasef, MM; Satija, S; Mehta, M; Pabreja, K; Mishra, V; Khan, M; Abobaker, S; Azzouz, IM; Dureja, H; Pabari, RM; Dardouri, AAK; Kesharwani, P; Gupta, G; Dhar Shukla, S; Prasher, P; Charbe, NB; Negi, P; Kapoor, DN; Chellappan, DK; Webba da Silva, M; Thompson, P; Dua, K; McCarron, P; Tambuwala, MM
2020-11-16Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier based Drug Delivery Systems.Mehta, M; Dhanjal, DS; Satija, S; Wadhwa, R; Paudel, KR; Chellappan, DK; Mohammad, S; Haghi, M; Hansbro, PM; Dua, K
2020-11-06Potential Anti-epileptic Phytoconstituents: An Updated Review.Kaur, J; Famta, P; Famta, M; Mehta, M; Satija, S; Sharma, N; Vyas, M; Khatik, GL; Chellappan, DK; Dua, K; Khurana, N
2020-11-04Interferon therapy for preventing COPD exacerbationsMehta, M; Paudel, KR; Shukla, SD; Shastri, M; Singh, SK; Gulati, M; Dureja, H; Gupta, G; Satija, S; Hansbro, PM; Chellappan, DK; Dua, K
2020-11Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesisMehta, M; Prasher, P; Sharma, M; Shastri, MD; Khurana, N; Vyas, M; Dureja, H; Gupta, G; Anand, K; Satija, S; Chellappan, DK; Dua, K
2020-11Beta-catenin non-canonical pathway: A potential target for inflammatory and hyperproliferative state via expression of transglutaminase 2 in psoriatic skin keratinocyte.Gupta, G; Singh, Y; Tiwari, J; Raizaday, A; Alharbi, KS; Al-Abbasi, FA; Kazmi, I; Satija, S; Tambuwala, MM; Devkota, HP; Krishnan, A; Chellappan, DK; Dua, K
2020-10-30Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549.Solanki, N; Mehta, M; Chellappan, DK; Gupta, G; Hansbro, NG; Tambuwala, MM; Aa Aljabali, A; Paudel, KR; Liu, G; Satija, S; Hansbro, PM; Dua, K; Dureja, H
2020-10-05Targeting interleukins in chronic airway diseases using advanced drug delivery.Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Dua, K
2020-09-24Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.Mehta, M; Satija, S; Paudel, KR; Malyla, V; Kannaujiya, VK; Chellappan, DK; Bebawy, M; Hansbro, PM; Wich, PR; Dua, K
2020-09-01Emerging trends of liquid crystalline nanoparticles drug delivery for pulmonary disordersSingh, VP; Mehta, M; Satija, S; Sharma, DS; Sharma, PK
2020-09Vesicular drug delivery systems as theranostics in COVID-19.Satija, S; Mehta, M; Sharma, M; Prasher, P; Gupta, G; Chellappan, DK; Dua, K
2020-09COVID-19 transmission through host cell directed network of GPCR.Singh, Y; Gupta, G; Satija, S; Pabreja, K; Chellappan, DK; Dua, K
2020-08-17Plant-based drug delivery systems in respiratory diseasesMehta, M; Sharma, P; Kaur, S; Dhanjal, DS; Singh, B; Vyas, M; Gupta, G; Chellappan, DK; Nammi, S; Singh, TG; Dua, K; Satija, S; Dua, K; Hansbro, P; Wadhwa, R; Haghi, M; Pont, L; Williams, K
2020-08-06Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.Tan, YY; Yap, PK; Xin Lim, GL; Mehta, M; Chan, Y; Ng, SW; Kapoor, DN; Negi, P; Anand, K; Singh, SK; Jha, NK; Lim, LC; Madheswaran, T; Satija, S; Gupta, G; Dua, K; Chellappan, DK
2020-07-30Probing 3CL protease: Rationally designed chemical moieties for COVID-19.Sharma, M; Prasher, P; Mehta, M; Zacconi, FC; Singh, Y; Kapoor, DN; Dureja, H; Pardhi, DM; Tambuwala, MM; Gupta, G; Chellappan, DK; Dua, K; Satija, S